SEC Tracker
Get the app

Editas Medicine EDIT

Gilmore Neil O'Neill (Officer) plans to sell 35,000 EDIT shares, about $65,100

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: Mar 3, 2025
  2. Broker: ETrade Financial Corporation
  3. Shares acquired by: Restricted Stock Unit Vesting
  4. 10b5-1 plan adopted: Apr 13, 2022

All of Gilmore Neil O'Neill's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 16,632 shares at $1.71 on Mar 4, 2025 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Editas Medicine files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Merus MRUS
  2. Palvella Therapeutics PVLA public float $197M, Jun 30, 2025
  3. Esperion Therapeutics ESPR public float $198M, Jun 30, 2025
  4. Rezolute RZLT public float $204M, Dec 31, 2025
  5. Cardiff Oncology CRDF public float $205M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.